Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 119

More PCC Articles

JCP
Original Research

November 23, 2016

Several antipsychotics have shown efficacy for schizophrenia in controlled settings, but how effective are they in the long-term treatment of individuals in community settings? Learn how 7 antipsychotics compared…
Chen Zhang, Mei-Juan Chen, Guo-Jun Wu, et al
JCP
Original Research

November 23, 2016

As many as 25% of patients with first-episode psychosis experience nonremission or treatment resistance. Read this article to see whether initiating clozapine earlier in treatment can lead to better…
Charmaine Tang, Mythily Subramaniam, Boon Tat Ng, et al
JCP
Original Research

November 23, 2016

Is clozapine safe for patients with benign neutropenia? Many patients with lower than normal absolute neutrophil count do not qualify for clozapine therapy or are at risk of having…
Charles M. Richardson, Erica A. Davis, Gopal R. Vyas, et al
JCP
Article

November 23, 2016

Does a relationship exist between mothers with postnatal depression and cognitive outcomes of their children? This meta-analysis article explores whether postnatal depression is a risk factor for a child’s…
Guoyuan Sui, Bochen Pan, Guangcong Liu, et al
JCP
Article

November 23, 2016

Read this article discussing the needs of socioeconomically disadvantaged women with antenatal (prenatal ) depression.
Marlene P. Freeman
JCP
Academic Highlights

November 23, 2016

Do low oxytocin levels in patients with anorexia nervosa (AN) result from low weight, or do they persist even after recovery? To answer this question, this study measured oxytocin…
Yuliya Afinogenova, Cindy Schmelkin, Franziska Plessow, et al
JCP
Article

November 23, 2016

If you lack complete and up-to-date medication data for your patients, how can you correctly evaluate their clinical status and adjust the medication regimen that you’ve prescribed? Read this…
Mirjam Simoons, Hans Mulder, Arne J. Risselada, et al
JCP
Original Research

November 23, 2016

Aripiprazole lauroxil, a long-acting injectable antipsychotic, demonstrated safety and efficacy in treating schizophrenia symptoms in a recent RCT. But how does it stack up against other antipsychotics in terms…
Henry A. Nasrallah, John W. Newcomer, Robert Risinger, et al
JCP
Original Research

November 23, 2016

Knowing that patients with posttraumatic stress disorder and substance use disorder share impaired prefrontal cortex regulation, particularly at glutamate synapses in the nucleus accumbens, the authors conducted this first-ever…
Sudie E. Back, Jenna L. McCauley, Kristina J. Korte, et al
JCP
Original Research

November 23, 2016

Some have argued that changes to the diagnostic criteria for PTSD in the DSM-5 would increase rates of comorbidity between PTSD and other psychiatric disorders. Find out whether that…
Blair E. Wisco, Brian P. Marx, Mark W. Miller, et al
JCP
Academic Highlights

November 23, 2016

Will the psychiatric medication that your female patient is already taking be a risk factor for development of hypertension, preeclampsia, or eclampsia when she is pregnant? In this study,…
D. Jeffrey Newport, Amy L. Hostetter, Sarah H. Juul, et al
JCP
Clinical and Practical Psychopharmacology

November 23, 2016

Metformin is emerging as an important option for preventing or treating weight gain, type 2 diabetes, and metabolic syndrome in psychiatric patients. Here, Dr Andrade outlines the safety issues…
Chittaranjan Andrade

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe